Obesity‐related NAFLD manifestation by metabolic syndrome is a prevalent public health issue, has been consistently linked to a range of disorders comprising dyslipidemia, hypertension, resistance to insulin, and a greater vulnerability to cardiovascular mortality (Savini et al. 2013; Fazel et al. 2016). The gene discussed is INS; the disease is metabolic syndrome.